SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Izzy who wrote (1983)10/2/1997 11:14:00 AM
From: Tom DuBois   of 6136
 
Izzy...my advice is to listen to the real options experts who have posted today in response to your question. They are clearly more experienced than I in these matters. I am very niave I guess...my approach is far simpler and very much less scientific than the TA others describe.

I believe that the combination of earnings, good?? news from Toronto and European approval (less likely now) will push AGPH back to $55 by expiration of the Nov options. I am long the underlying stock and see an opportunity to make a quick pop if I am right. Conversely, I'll take a quick hit if I'm wrong.

When it comes to options, guess I'm more of a gambler than an investor or speculator. Listen to the others...my "system" is my gut.

BTW... thank you to the options posters. Interesting info and references. Maybe I'll actually abandon my "seat of the pants" approach and get technical!!

Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext